Nowak, Albina; Dormond, Olivier; Monzambani, Véronique; Huynh-Do, Uyen; Barbey, Frédéric (2022). Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity. Molecular genetics and metabolism, 137(1-2), pp. 173-178. Elsevier 10.1016/j.ymgme.2022.08.003
|
Text
1-s2.0-S1096719222003900-main.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (527kB) | Preview |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension |
UniBE Contributor: |
Huynh-Do, Uyen |
Subjects: |
600 Technology > 610 Medicine & health 500 Science > 570 Life sciences; biology |
ISSN: |
1096-7192 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Uyen Huynh-Do |
Date Deposited: |
27 Mar 2023 08:26 |
Last Modified: |
27 Mar 2023 23:27 |
Publisher DOI: |
10.1016/j.ymgme.2022.08.003 |
PubMed ID: |
36087505 |
BORIS DOI: |
10.48350/180660 |
URI: |
https://boris.unibe.ch/id/eprint/180660 |
Actions (login required)
 |
Edit item |